No human trials administering or targeting IL-10 have so far been reported, but studies using the non-obese diabetic (NOD) mouse model of T1D found that IL-10 has protective effects on diabetes development [14, 15]. The gene discussed is IL10; the disease is type 1 diabetes mellitus.